Diagnostics Inc reports results for the quarter ended in March - Earnings Summary

Co-Diagnostics

11/05/2023 21:16

* Co-Diagnostics Inc  CODX.OQ  reported a quarterly adjusted
loss
of 20 cents​​ per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 22 cents per share.
    * Revenue fell 97.4% to $601.00 thousand from a year ago;
analysts
expected $1.10 million. 
    * Co-Diagnostics Inc's reported EPS for the quarter was a
loss
of 20 cents​.
    * The mean earnings estimate of analysts had fallen by
about 53.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Co-Diagnostics Inc shares had fallen by 11.1% this
quarter and
lost 47.8% so far this year.
    * The company reported a quarterly loss of $5.76 million.
    * Wall Street's median 12-month price target for
Co-Diagnostics
Inc is $4.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 08:16 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.22          -0.20          Beat
 Dec. 31 2022      -0.15          -0.68          Missed
 Sep. 30 2022      -0.04          -0.04          Met
 Jun. 30 2022      0.10           -0.08          Missed